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Background: Severe fatigue may persist for many years in cancer survivors and has a considerable impact on a
patient's life. This condition is called cancer-related fatigue (CRF). Mindfulness-Based Cognitive Therapy has
shown to signiﬁcantly reduce CRF in cancer survivors. Internet-delivered interventions can be valuable for
fatigued patients who are not able to travel to a healthcare institute because of the lack of energy and/or physical
limitations. Therefore, we have developed a web-based, therapist guided individual 9-week Mindfulness-Based
Cognitive Therapy (eMBCT) aimed at diminishing CRF.
Objective: The aim of this study was to evaluate the efﬁcacy of eMBCT in a clinical setting in reducing fatigue
severity and distress in cancer survivors.
Methods: This pilot study was based on data from severely fatigued cancer survivors who applied for eMBCT
between 2009 and 2013. Our primary outcome measure was the change in self-reported web-assessed fatigue
severity, measured with the Fatigue severity subscale of the Checklist Individual Strength before (baseline)
and onemonth after (post-assessment) eMBCT. The secondary outcomewas distress (HADS) and the proportion
of participants that showed clinically relevant improvement on fatigue severity. Patients' satisfaction with using
eMBCT and reasons for non-adherence were studied. Intention-to-treat analyses were performed using multiple
imputations to dealwith data loss at post-assessment. All patients had to be severely fatigued at baseline (≥35on
the fatigue severity subscale of the Checklist Individual Strength),were N18 years old, had no history of psychosis
or current Major Depressive Disorder, ﬁnished their last cancer treatment at least six months ago (mixed cancer
types), and were not in the terminal phase of illness. Patients were recruited ofﬂine as well as online.
Results: Two-hundred ﬁfty-seven patients (age range 22–79 (M=50.2, SD=10.7), 76%women, 44% breast can-
cer, most had had surgery, chemo- and/or radiotherapy) met our inclusion criteria. Paired samples t-tests
showed that fatigue severity was signiﬁcantly reduced post-assessment (t(18) = 13.27, p b .001, Cohen's d:
1.45 as well as distress (t(46) = 7.66, p b .001, Cohen's d: 0.71). Thirty-ﬁve percent (n = 89) was clinically
relevant improved at post-assessment and 62% (n = 159) adhered to treatment. This study had a completion
rate of 1.5 and a registration rate of 2.3.
Conclusion: Theseﬁndings suggest that individual eMBCTmay be effective in reducing fatigue in cancer survivors.
A randomized controlled studywith a large sample and longer follow up is needed to demonstrate the effective-
ness of eMBCT for CRF.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Fatigue is a common side-effect of cancer and its treatment (Servaes
et al., 2003; Bower, 2005; Van der Geest et al., 2013). Cancer-relatedF, Cancer-Related Fatigue; ITT,
herapy; CIS, Checklist Individual
I, Clinically Relevant Improved;
ment, Helen Dowling Institute,
en, The Netherlands. Tel.: +31
).
. This is an open access article underfatigue (CRF) is deﬁned as a distressing persistent, subjective sense of
physical, emotional and/or cognitive tiredness or exhaustion related to
cancer or cancer treatment that is not proportional to recent activity
and interferes with usual functioning (Berger et al., 2014). In about
one third of cancer survivors fatigue may persist for months or even
years after cancer treatment (Nieboer et al., 2005; Goedendorp et al.,
2013; Heutte et al., 2009; Hjermstad et al., 2005; Storey et al., 2012).
Fatigue is known as one of the most prevalent and distressing long-
term consequences of cancer (Bower, 2008; Díaz et al., 2008; Jansen
et al., 2011; Oerlemans et al., 2013). It is associated with high levels of
depression and anxiety (Prue et al., 2006; Smets et al., 1993; Goldstein
et al., 2006), and has an impact on patient's ability to reintegrate intothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Netherlands alone, at least 156.000 cancer survivors are suffering from
fatigue (Goedendorp et al., 2013; Meulepas et al., 2011a). This number
is expected to rise in the next decades, as the number of people surviv-
ing cancer is increasing (Meulepas et al., 2011b).
The etiology of CRF is complex and multidimensional (Koornstra
et al., 2014), as it most likely involves physiological, biochemical and
psychological systems (Ryan et al., 2007). Most commonly identiﬁed
factors that contribute to CRF include 1) tumor-related factors and
complications (e.g. anemia, pain, appetite loss, stress), 2) treatment
side effects (e.g. tissue damage due to cytostatica, or radiation,
medication side effects), 3) comorbid medical condition (e.g. thyroid
dysfunction, diabetes mellitus, chronic obstructive pulmonary
disease) 3) exacerbating comorbid symptoms (sleep disturbance,
deconditioning, chronic pain) and 4) psychosocial factors (coping with
illness, anxiety, depression) (Koornstra et al., 2014; Wagner and Cella,
2004).
In the National Comprehensive Cancer Network (NCCN) guidelines
for CRF (Berger et al., 2014) psychosocial interventions are recommend-
ed for CRF both during active cancer treatment, as well as after treat-
ment. These interventions are aimed at changing inefﬁcient coping
strategies (Berger et al., 2014;Mock, 2003), thus changing the behavior-
al and cognitive reactions of the patient to cancer-related stressors in-
cluding fatigue itself (Duijts et al., 2011; Gielissen et al., 2006; Van der
Lee and Garssen, 2012). Mindfulness-Based Cognitive Therapy (MBCT)
has shown to be effective in reducing severe fatigue in cancer survivors
in a randomized controlled trial (Van der Lee and Garssen, 2012).
Mindfulness-based interventions have been found to have a positive ef-
fect on psychological and physiological symptoms in cancer survivors
(Ledesma and Kumano, 2009; Foley et al., 2010; Ott et al., 2006;
Hofmann et al., 2010). Baer (2003) proposed that mindfulness skills
can lead to symptom reduction and behavior change through exposure,
cognitive change, self-management, relaxation and acceptance. In Fig. 1
the proposedmechanisms by Baer are presented, and applied to CRF by
the authors.I. Exposure The ability to observe fatig
reduce distress associate
II. Cognitive change The practice of mindfulnes
towards one’s thoughts. F
feeling so fatigued all the 
of truth or reality. Patients
these thoughts.
III. Self-management Through the practice of m
awareness to the present 
maladaptive coping strate
catastrophizing about fatig
raising awareness people
strategy.
IV. Relaxation By raising awareness to b
autonomic arousal, and ra
to relaxation. Relaxation h
rest.
V. Acceptance Mindfulness meditation in
feelings, urges, or other b
way the patients can save
change, escape, or avoid 
Fig. 1. How MBCT may help Ott et al., 2006— app1.1. Web-based Mindfulness-Based Cognitive Therapy for cancer survivors
Internet-delivered psychosocial interventions can serve as an addi-
tion to existing face-to-face interventions (Cuijpers et al., 2008;
Andersson et al., 2014; Boettcher et al., 2014). It makes treatment
available for patients who are unable to travel to a healthcare institute,
because of lack of energy or physical limitations. Also, internet interven-
tionsmay be suitable for patients who seek treatment that is easy to in-
tegrate into daily life activities, as one can follow the programwhen and
wherever preferred. We have developed a web-based individual MBCT
aimed at alleviating CRF called eMBCT. The eMBCT is characterized by
personal contact with one assigned therapist via e-mail and follows
the same protocol as face-to-face MBCT for CRF (see Appendix A)
(Van der Lee and Garssen, 2012). MBCT is originally delivered in a
group format. IndividualMBCT can be beneﬁcial for patientswho are re-
luctant to treatment in a group, for instance because they fear being
confronted with stories of fellow patients. Individual MBCT has been
shown to be effective in reducing depression in patient with diabetes
(Tovote et al., 2014). As far as we know, this pilot study is the ﬁrst to in-
vestigate a web-based individual MBCT for CRF.
1.2. Development of eMBCT
In the development of eMBCT, we originally adopted the 9-week
face-to-face MBCT protocol for CRF (Van der Lee and Garssen, 2012),
and made the following adaptations: We re-designed the reader with
a professional lay-out, and added a written introduction which was
originally given in the group face-to-face. The weekly reader was divid-
ed in paragraphs, describing each psycho-educational theme separately,
and thereby improving readability.We transformed the audio ﬁles from
the face-to-face MBCT to digital MP3 ﬁles. We added written instruc-
tions for the exercises ‘eatingwith awareness’ and ‘walkingmeditation’,
as these exercises were originally done in the group in the face-to-face
MBCT. We illustrated the yoga exercises in the reader so patients
could easily copy the yoga postures.ue sensations non-judgmentally is believed to 
d with fatigue through desensitization.
s may lead to changes in one’s attitude
atigue-related thoughts like: “I am useless,
time” are ‘just thoughts’ rather than reflections 
 are stimulated to cognitively defuse from 
indfulness a patient can learn to raise 
experience and becomes aware of potentially 
gies (e.g. irritation in social contact, 
ue, being overactive, or being too inactive). By 
 are able to choose a more helpful coping 
odily sensations such as muscle tension, 
cing thoughts, mindfulness exercises may lead 
as a beneficial effect on quality of sleep and 
cludes acceptance of fatigue-related thoughts, 
odily, cognitive and emotional reaction. In that 
 energy which is otherwise spilled on trying to 
fatigue.
lied to cancer-related fatigue by the authors.
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Dowling Institute, 2009) (SSL encrypted)with thehelp of an ICT compa-
ny called Studio2 (Studio2 Communications BV, 2015) (see Appendix D
for screenshots). The 9-week protocol, the readers, MP3 ﬁles, and log
boxeswere implemented. On this website, patients aswell as therapists
could log in on their personal webpage with a username and password.
In the log boxes patients couldwrite down their experienceswith doing
the exercises. An e-mailbox was implemented on the webpage, so
patients could securely correspond with their personal therapist, and re-
ceive feedback on their logﬁles. An extensive intake procedure containing
state and trait questionnaires was designed and put on the webpage. See
Section 2.3 for more information about setting and intervention.
Five fatigued cancer patients, who had previously followed face-to-
face MBCT for CRF (Van der Lee and Garssen, 2012), volunteered to fol-
low theﬁrst version of eMBCT and gave feedback about user friendliness
and usability. Following their feedback, we addedMP3 ﬁles of the same
exercises (male voice, female voice, and shorter versions) so patients
could choose which exercise they preferred. We added an option to
print out the log ﬁles and e-mail correspondence with the therapist.
We improved navigation on the webpage and enlarged the log boxes.
An online forumwas suggested to share experiences with mindfulness,
and to help continue practicing after the intervention had ﬁnished.
Though, as the costs of a moderator would not be compensated by the
health insurance companies, we instead referred to awebsite for the pa-
tient to ﬁnd mindfulness meetings nearby.
1.3. Aim of this study
The aimof this studywas to evaluate the efﬁcacy of eMBCT in a clinical
setting in reducing fatigue severity and distress in cancer survivors.
2. Material and methods
2.1. Patients
Participants in this pilot study had to meet the following inclusion
criteria: they (a) were a cancer survivor (all cancer types included),
meaning either they had cancer but were not in the terminal phase of
illness, or had suffered from cancer in the past (b) had completed
their last cancer treatment at least six months before the start of
eMBCT (hormonal treatment excluded); (d) were older than 18 years;
(e) scored ≥ 35 on the severity of fatigue subscale of the self-report
Checklist Individual Strength (CIS) at baseline (Vercoulen et al., 1999);
(f) had no history of psychosis or current Major Depressive Disorder. If
patients followed any other form of psychological care for fatigue or
changed their medication considerably during the eMBCT, this was reg-
istered at post-assessment (self-report). Patients who reported they
had cancer recurrence or started a cancer treatment during the study
were excluded from analysis. Co-morbid somatic diseases that were a
possible cause for fatigue were no exclusion criterion, but were regis-
tered during the study (self-reported).
2.2. Recruitment
We informed medical doctors about the eMBCT via articles in rele-
vant magazines, and informed patients directly by newsletters of pa-
tient associations, and via advertisements on relevant websites in the
Netherlands (see Appendix B for advertisement).
2.3. Setting and intervention
Patients were referred to the Helen Dowling Institute (a health care
institution, specialized in psycho-oncology, then situated in Utrecht, the
Netherlands) by medical doctors and all costs were compensated by
health insurance. The intervention was given by eleven therapists (see
Appendix C for case volume), who had at least two years of experiencewith face-to-face MBCT for cancer patients. They were trained in giving
the nine-week eMBCT protocol (see Appendix A) and attended supervi-
sion bimonthly. Patients registered for eMBCT via the website (www.
mindermoebijkanker.nl) (Helen Dowling Institute, 2009). They ﬁlled
in the fatigue severity subscale and were given immediate automated
feedback on their fatigue severity. In case their scores indicated severe
fatigue, patients could register for eMBCT. After registration, patients
were asked to agree on the general usage conditions and ﬁll in the in-
take questionnaire on their personal webpage. Then, their personal
therapist gave feedback on the intake and judged whether eMBCT
would be suitable for them. If the therapist had doubts about whether
eMBCT was adequate care for the patient, the therapist contacted pa-
tients via telephone for inquiry. To start the intervention, patients
could log on to their personal webpage where they could download
MP3 ﬁles with exercises, read written information about a speciﬁc
mindfulness theme each week in the weekly reader, and to correspond
with their personal therapist via e-mail (see Appendix D for
screenshots). Patients were asked to practice the mindfulness exercises
six days a week for half an hour, and to document their experiences in
their personal log on their webpage. On an agreed day of the week,
the therapists replied to this weekly log, thereby guiding the patients
through the nine-week program. The therapist encouraged the patient
to try out the newmindfulness exercises and also do some of the exer-
cises of theweeks before (see Appendix A). Fromweek 7 on participants
could choosewhich exercises they preferred, and inweek 9 they created
their own program. The therapist provided the patient with personal
support in doing the exercises, and creating a mild and open awareness
for thoughts, feelings and behaviors. Patients could continue with the
next week's session after they had registered their experiences with
each exercise in their log of the previousweek. Patientswere stimulated
to follow the nine-week intervention within the nine weeks period. In
case of holidays or illness they could pause for aweek ormore in consul-
tation with their therapist. At the end of each week patients answered
eight questions about their wellbeing using the six items of the outcome
rating scale (Miller et al., 2003) and two self-created questionnaires
about fatigue and illness, so the therapists could monitor their patients
closely. In case a patient reported a drop in wellbeing, the therapist
contacted the patient for inquiry, to investigate if (additional) help
wasneeded from their general practitioner or other health professionals
nearby. An evaluation questionnairewas sent by e-mail fourweeks after
the intervention (see 2.4 Data collection). The therapist replied to this
evaluation questionnaire for one last time, and encouraged the patient
to continue practicing after the intervention had ﬁnished.
2.4. Data collection
On their personal webpage, patients ﬁlled in questionnaires
concerning fatigue severity and distress before (baseline intake) the
nine-week intervention. Onemonth after the intervention (post-assess-
ment), patients were sent an invitation via e-mail to ﬁll in the post-
assessment questionnaire via a password secured online questionnaire.
IP addresses were used to distinguish post-assessment questionnaires
between patients. Patients were able to review and modify their
answers through a ‘back’ button. All items of the fatigue severity and
distress questionnaires were mandatory. Regarding satisfaction with
eMBCT, all patients were sent an evaluation questionnaire post-
assessment. The data were collected in a clinical setting, and was
approved by the ethical board of the Helen Dowling Institute. In the
general usage conditions, patients agreed on their answers to the ques-
tionnaires being used for research purposes.
2.5. Measures
2.5.1. Primary outcome variable: fatigue severity
Fatigue severity was assessed with the fatigue severity subscale of
the Checklist Individual Strength (CIS) (Vercoulen et al., 1999). The
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7-point Likert scale and demonstrated acceptable to excellent reliability
(Vercoulen et al., 1994) and internal consistency (Stulemeijer et al.,
2005). In this study, Guttman's λ2 (Guttman, 1945; Sijtsma and
Emons, 2011) for the CIS subscale fatigue severity was .75 at baseline
and .93 at post-assessment. Patients with a score of N35 on this subscale
are considered to suffer from severe fatigue (Gielissen et al., 2006;
Vercoulen et al., 1994). The CIS has been used to assess fatigue in cancer
survivors (Gielissen et al., 2006; Servaes et al., 2002a, 2002b). It closely
resembles the Multidimensional Fatigue Inventory (Smets et al., 1996;
Smets et al., 1995), which is often used internationally for measuring
CRF. We chose the CIS, because a clinical cut off point for severe fatigue
is available for Dutch cancer survivors (Gielissen et al., 2006).
2.5.2. Secondary outcome variables: distress, clinically relevant improve-
ment, satisfaction
Distress is a common symptom in cancer patients, and is often asso-
ciated with fatigue severity (Nieboer et al., 2005; Brown et al., 2013;
Brown and Kroenke, 2009). Therefore distress was used as our second-
ary outcome measure and was assessed with the Hospital Anxiety and
Depression Scale (HADS) (Zigmond and Snaith, 1983). The HADS is a* Numbers do not add up as multiple exclusion crit
Fig. 2. Flowself-report questionnaire that comprises 14 items measuring feelings
of generalized fear and depressive symptoms. The HADS is considered
a reliable and valid instrument in medical patients and is sensitive to
change (Herrmann, 1997; Bjelland et al., 2002). A Dutch validation
study showed good reliability (Spinhoven et al., 1997). Le Fevre et al.
(1999) showed that N20 on the total scale is a good cut off point to
screen for depression in cancer patients. In this study, Guttman's λ2
(Guttman, 1945; Sijtsma and Emons, 2011) for the HADS was .85 at
baseline and .85 at post-assessment. We calculated the percentage of
clinically relevant improved patients at post-assessment on fatigue
severity. Also, we calculated how many patients were less fatigued,
how many patients did not respond to treatment, and how many pa-
tients reported more fatigue after treatment (Rozental et al., 2014).
Concerning patients' satisfaction with eMBCT, we asked adherent pa-
tients about their opinion on the duration of, the amount of homework,
and what grade they would give their therapist on a scale from 1 to 10.
Adherent patients were asked about what they thought had helped
them most and what they would like to see improved about eMBCT.
Non-adherent patients were also asked what they would like to see im-
proved about eMBCT, and were asked for their reason to stop using the
intervention. The post-assessment questionnaire for non-adherenteria are possible
chart.
Table 1
Baseline characteristics of study participants (n = 257).
Mean (SD)/%
Age (years) 50.2 (10.7)
Women 76.3
Dutch nationality 97.7
Living with partner and/or children 69.6
Education
Low 5.8
Middle 37.7
High 50.6
Employmenta
Paid job 54.5
Disability insurance act 29.2
Absenteeism from work 36.2
Cancer typea
Breast 44.0
Blood bone marrow, Hodgkin 12.1
Digestive system 6.6
Reproductive organs 7.0
Head and neck 4.7
Other 8.1
More than one cancer type 11.3
Cancer recurrence 6.6
Heredity form of cancer 3.5
Lymph nodes affected 42.0
Metastases 16.0
Type of cancer treatmenta
Surgery 67.7
Chemotherapy 60.3
Radiotherapy 55.3
Hormonal therapy 28.4
Immunotherapy 7.8
Stem cell transplantation 2.7
No treatment: wait and see 0.8
Other 5.4
Suffer from co morbidity 27.2
Of these, percentage that suffers from
two or more co morbidities
18.6
Co morbidityb
Infection 20.7
Spine 13.4
Blood 9.8
Thyroid 8.5
Lung 8.5
Diabetes 7.3
Chronic fatigue syndrome, myalgic encephalomyelitis 6.1
Pain, ﬁbromyalgia 6.1
Fear or mood disorder 2.4
Psoriasis, eczema 2.4
Migraine 2.4
Other 12.4
Medicine usea
Pain 24.1
Tension 7.0
Sleep 13.2
Antidepressants 10.1
For cancer 23.7
Time since last cancer treatment (years) 2.93(3.29)
(range 0.5–22)
Time since diagnosis (years) 3.44 (2.42)
(range 0.08–22.75)
HADS ≥20 at baseline 26.46
Duration of fatigue 4.11 (1.29)
1 = 0–5 months 9.0
2 = 6 months–1 year 22.6
3 = 1–2 years 24.9
4 = 2–5 years 26.8
5 = more than 5 years 14.8
Patient's own estimated prognosis
Positive 56.8
Unclear, uncertain 17.1
Negative 2.3
I don't know 8.9
No experience with attention-focused
exercises, such as meditation or yoga
31.1
Duration completing 70% of intervention
(weeks)
15.53 (10.12),
ranging from 7 to 64
204 F.Z. Bruggeman Everts et al. / Internet Interventions 2 (2015) 200–213patients was shorter than adherent patients, as we expected that a
long evaluation questionnaire would not be ﬁlled in by non-
adherers, leading to loss at post-assessment. A patient was consid-
ered adherent if he or she had followed at least 70% of the interven-
tion. We chose 70%, as we expect that by week 6 patients have
experienced enough content of the intervention to could beneﬁt
from it (Christensen et al., 2009).
2.5.3. Patient characteristics
Demographic and medical information (marital status, age, gender,
work status, education, cancer type, medicine use, treatment, time
since treatment) was collected at baseline via self-report.
2.5.4. Control variables
At post-assessment patients registered important changes that
could have inﬂuenced their fatigue over the last four months, such as
changes inmedication, following another treatment for fatigue, divorce,
starting a new medical treatment, or cancer recurrence.
2.6. Statistical analysis
A paired samples t-test was used to investigate changes on the pri-
mary outcome CIS fatigue severity subscale, and secondary outcome
HADS, both between baseline andpost treatment.We usedmultiple im-
putation algorithms (Predictive Mean Matching) to deal with missing
values at post-assessment (Schenker and Taylor, 1996; Heitjan and
Little, 1991). Firstly, we performed an intention-to-treat (ITT) analysis
including both adherent and non-adherent patients. Secondly, we ana-
lyzed change scores for only adherent patients. To measure the effect
size for the dependent samples t-test analyses, Cohen's dwas calculated
as followed: Cohen's d=mean difference/standard deviation of the dif-
ference (Borenstein et al., 2009). Signiﬁcance level was set at p≤ .05. To
assess clinical relevance in fatigue severity change, a patientwas consid-
ered clinically improved if the following two conditions were met:
1) the reliable change index (RCI) should be more than 1.96 (Jacobson
and Truax, 1991), and 2) the post score should be within the normal
range, that is a score b 1 standard deviation above themean of a norma-
tive group (Servaes et al., 2002c), i.e. a score b 30.4 on CIS fatigue sever-
ity subscale. Moreover, we used the RCI to calculate the number of
patients who were less fatigued (RCI N 1.96), did not respond to treat-
ment (RCI between 1.96 and −1.96), and who were more fatigued
after treatment (RCI b−1.96). The demographic, medical history and
outcome variables were described using frequency and descriptive
statistics. To see if there were differences at baseline between non-
adherent and adherent patients, we checked the following characteris-
tics using t-tests and χ2-tests: depression (HADS≥ 20), fatigue severity
at baseline, prognosis, marital status, age, gender, employment,
education, cancer type, medicine use, treatment type, previous experi-
ence with meditation, and time since cancer treatment. Analyses were
performed using SPSS Version 19 for Windows package (SPSS Inc,
Chicago, IL).
3. Results
Between October 2009 and February 2013 1516 people ﬁlled in the
fatigue severity subscale on the website (www.mindermoebijkanker.
nl), of which 98% (n=1485) scored N 35 and thus were given the auto-
mated feedback that they could apply for eMBCT. Eventually, 619 pa-
tients registered for the intervention, out of which 423 ﬁlled in the
intake questionnaire (see Fig. 2 for ﬂowchart). This gives a registration
rate of 2.3 (ratio unique visits to website/registered) and a completion
rate of 1.5 (ratio agreed to participate/ﬁnished survey). For this study,
we had to exclude 169 patients, leaving 257 patients that were eligible
and started the intervention. Of these, 38.1% (n= 98) were not adher-
ent as they stopped using the intervention before completing 70%, in-
cluding 15.6% (n = 40) that did not start the intervention after they
Table 1 (continued)
Mean (SD)/%
Non-adherent 38.1
Followed any other form of psychological
care for fatigue at baseline
15.5
Changed medication considerably during
the eMBCT
8.9
eMBCT = web-based Mindfulness Based Cognitive Therapy; M =mean; SD = standard
deviation; HADS = Hospital Anxiety Depression Scale.
a Percentages do not add up to 100% because multiple options are possible.
b Infection including Sarcoidosis, Bechterew's disease, Crohn's disease, Graves' disease,
rheumatoid arthritis. Spine injury including whiplash and hernia. Blood including heart
problems, high blood pressure, polycytemia vera. Lung diseases including ﬁbrosis, asthma,
bronchitis, emphysema.
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vention within 16 weeks. Demographic characteristics at baseline are
presented in Table 1.
3.1. Multiple imputation of missing data using predictive mean matching
and predictors of dropout
To select auxiliary variables formultiple imputation, we investigated
differences between dropouts (patients who did not ﬁll in the post-
assessment questionnaire, Christensen et al., 2009) and non-dropouts,
using independent samples t-tests andχ2-tests. This showed that drop-
outs had been suffering from fatigue shorter (χ2(6)= 14.96, p= .021),
had relatively lower education (χ2(2) = 15.71, p b .001), were more
often men (χ2(1) = 3.846, p b .05), had less often breast cancer
(χ2(1) = 5.00, p = .025), had ‘other’ cancer type more often
(χ2(1) = 6.99, p = .008), had a less good prognosis (χ2(4) = 11.13,
p = .025), suffered from comorbidity more often (χ2(1) = 5.52, p =
.019), were less often occupied with household activities (χ2(1) =
4.96, p= .026), and reported a poorer quality of life at baseline (mea-
suredwith one 10-point scale question:Howwould you rate your quality
of life?) (t(164) = −2.64, p = .009). These variables were used as
auxiliary variables for imputation fatigue and distress scores at post-
assessment. The pooled mean of the imputed dataset consisting of 5
iterations, was used for the analyses.
3.2. The efﬁcacy of eMBCT on fatigue severity and distress
Paired samples t-test in the ITT analysis indicated that patients expe-
rienced less fatigue severity after the intervention than before the inter-
vention, with a large effect size (see Table 2a). Analysis of adherent
patients gave comparable results (see Table 2b). The proportion of clin-
ically relevant improved patients in the ITT analysis was 34.9% (n=89)
and for the adherent patients 36.8% (n= 59).
Concerning our secondary outcome distress, paired samples t-test in
the ITT analysis indicated that on average, patients experienced less dis-
tress after the intervention than before the intervention with a moder-
ate effect size (see Table 2a). The number of patients who were less
fatigued after treatment was 82.5% (n = 212). We found that 6.5%
(n= 17) did not respond to treatment, and 11.0% (n= 28) was more
fatigued after treatment.Table 2a
Intention-to-treat analysis. Paired samples t-test results of baseline and post assessment fatigue
n Baseline Post ass
M (SD) M (SD)
CIS–fatigue severity 257 46.53 (5.70) 33.89 (
HADS 257 15.48 (6.76) 10.90 (
CIS–fatigue severity = Checklist Individual Strength–Fatigue severity subscale; HADS = Hospi3.3. Satisfaction with eMBCT
Adherent patients who ﬁlled in the post-assessment questionnaire
(n = 133) rated the guidance by the therapist with an average grade
of 8.0 (SD= 1.2) on a scale from 1 to 10. Most of these patients found
the duration of eMBCT (78.9%; n=105), and the amount of homework
adequate (66.9%; n = 89). Patients reported that doing the exercises
(especially breathing, yoga, body scan and meditation), writing down
their experiences (reﬂect on their thoughts, feelings and behaviors),
and receiving feedback from their therapist (feeling supported, receiv-
ing mild, understanding feedback) were factors that were most helpful
in eMBCT. Patients wrote that eMBCT had helped them by learning to
accept their fatigue, recognizing which factors (situations, thoughts,
feelings, behaviors) are energy giving or energy taking, letting go of en-
ergy consuming thoughts, recognizing their boundaries and pitfalls,
managing communicating their boundaries with others, and accepting
not being the same person as before the cancer and treatments. We
asked both adherent as well as non-adherent patients to give their
feedback on what they would improve about e-MBCT. This question
was answered by 158 patients (25 non-adherent and 133 adherent).
The majority (55.1%; n = 87) said the intervention did not need im-
provement. The following issues were suggested for improvement:
a) Usability of webpage: Patients said it was difﬁcult to navigate on the
webpage, and the box for the log ﬁle was too small to write down
long texts (n = 27); b) Intensity: Patients reported that they needed
more time to do the 9-weekly intervention program, as the program
was too intensive, both emotional, as well as due themany assignments
they had to do (n= 21); c) Guidance through the internet: Patients said
they had difﬁculty in explaining themselves in written words, and
would prefer face-to-face contactwith their therapist or contact by tele-
phone (n= 8).
We asked non-adherent patients (n = 25) for their reason to stop
using the intervention before completing 70%. Most patients stopped
because they found it difﬁcult to integrate the exercises in daily life
(n = 11). The second most frequent reason was that the intervention
was too intensive (n = 6). Other reasons were that fatigue had de-
creased or that a co-morbid illness had gotten worse, mindfulness or
online help did not suit them, or that the intervention was not what
they had expected.3.4. Differences in demographics and baseline characteristics of adherent
and non-adherent patients
In Tables 3a and 3b the results of the t-tests and χ2 -tests are pre-
sented, with ϕ as a measure of strength of the correlation between ad-
herence and variables that have two categories, and Cramer's V for
variables which have more than two categories. Signiﬁcant differences
between adherent and non-adherent patients were found on several
demographic characteristics. The group of non-adherent patients were
more often depressed at baseline (χ2(1) = 23.44, p b .001, V = .30,
were often more men (χ2(1) = 14.79, p b .001, V = − .24), and had
lower education (χ2(2) = 7.97, p= .019, V =− .18). They had a paid
job less often (χ2(1) = 4.46, p = .035, V = − .13), used sleeping
medication less often (χ2(1) = 3.91, p= .048, V=− .14), and had no
previous experience with mindfulness (χ2(2) = 11.30, p = .004,severity (CIS fatigue severity subscale) and distress (HADS) of the imputed dataset.
essment t-test p Cohen's d
10.67) t(18) = 13.27 b .001 1.45
6.10) t(46) = 7.66 b .001 0.71
tal Anxiety and Depression Scale;M=mean (standard deviation).
Table 3a
Cross tabulation of adherence and demographics.
Demographics Adherence χ2 Cramer's V
Adherent Non-adherent
Depressed (HADS ≥ 20) 40 (−2.4) 54 (3.0) 23.44⁎ .30
Male gender 25 (−2.1) 36 (2.6) 14.79⁎ .24
Living with partner 110 (− .1) 69 (.1) 0.04 .01
No paid job 61 (− .9) 46 (1.3) 4.46⁎ .13
High education 92 (1.1) 38 (−1.5) 7.97⁎ .18
Type of cancer treatment 113 (.6) 61 (− .7) 2.78 − .11
Surgery 100 (− .6) 55 (− .6) 1.48 .08
Chemotherapy 91 (.4) 51 (− .5) 0.86 .06
Radiotherapy 48 (.4) 25 (− .6) 0.75 .06
Hormonal therapy 14 (.5) 6 (− .6) 0.65 .05
Immunotherapy 10 (.5) 4 (− .6) 0.60 .05
Other
Cancer type
Breast 86 (.7) 43 (− .9) 2.92 .11
Blood bone marrow, Hodgkin 22 (.4) 11 (− .5) 0.41 .04
Digestive system 13 (− .2) 9 (.2) 0.07 .01
Reproductive organs 12 (− .9) 13 (1.1) 2.19 .10
Head and neck 9 (− .8) 10 (1.0) 1.77 .09
Good prognosis 99 (.6) 47 (− .8) 3.23 .12
Medicine use 42 (− .3) 10 (.5) 0.52 .05
Pain 13 (.1) 5 (− .1) 0.01 .01
Tension 29 (1.0) 5 (−1.5) 3.91⁎ .14
Sleep 19 (.1) 7 (− .2) 0.05 .02
Antidepressants 44 (.1) 17 (− .1) 0.03 .01
For cancer
No previous experience with
meditation
40 (−1.5) 40 (1.9) 11.30⁎ .24
Note. Adjusted standardized residuals appear in parentheses next to group frequencies.
⁎ p b .05.
Table 2b
Adherent patients. Paired samples t-test results of baseline and post assessment fatigue severity (CIS fatigue severity subscale) and distress (HADS) of the imputed dataset.
n Baseline Post assessment t-test p Cohen's d
M (SD) M (SD)
CIS–fatigue severity 159 46.12 (5.52) 34.02 (10.70) t(160) = 13.37 b .001 1.37
HADS 159 15.63 (6.66) 11.14 (5.75) t(561) = 7.46 b .001 0.72
CIS–fatigue severity = Checklist Individual Strength–Fatigue severity subscale; HADS = Hospital Anxiety and Depression Scale;M=mean (standard deviation).
206 F.Z. Bruggeman Everts et al. / Internet Interventions 2 (2015) 200–213V=− .18). Depression at baseline has amoderate correlation,meaning
there is a moderate association between depression at baseline and
non-adherence. All other correlations were small.
4. Discussion
4.1. Principal results
In this study, the efﬁcacy of an individual internet-delivered
Mindfulness-Based Cognitive Therapy for the treatment of cancer-
related fatigue, called eMBCT, was investigated in a clinical setting
(n = 257). As far as we know, this is the ﬁrst study to evaluate an
internet-delivered individual MBCT for CRF. Fatigue severity and dis-
tress signiﬁcantly decreased from baseline to post-assessment, with a
high effect size of 1.45 (Cohen's d). Intention-to-treat analysis showed
that in 34.9% of the patients, fatigue severity was clinically relevant de-
creased, meaning they no longer reported fatigue complaints. In 82.5%
of the patients fatigue decreased post-assessment, 6.5% did not respond
to treatment, and 11.0% was more fatigued after treatment.
Adherent patients (61.9%) reported that eMBCT had helped learning
1) to accept their fatigue or being the same person as before the cancer
and treatments (acceptance, see Fig. 1), 2) recognizing and managing
their boundaries and pitfalls (self-management), and 3) letting go of en-
ergy consuming thoughts (relaxation). Most patients were satisﬁed
with eMBCT, though somemade suggestions for improving the usability
of the webpage, lowering the intensity of the intervention, and provid-
ing additional face-to-face contact or contact by telephone. Non-
adherent patients said they stopped using the intervention because
they found it difﬁcult to integrate the intervention in daily life activities,
and/or found the intervention too intensive. We found a moderate cor-
relation between depression at baseline and non-adherence, therefore
these patients may need to be cautiously monitored by the therapist
during the intervention.
4.2. Strengths and limitations
As this study was based on data assessed in a clinical setting, our re-
search design has several limitations. First of all, we used a design with-
out a control group and therefore cannot control for other factors that
could explain change in fatigue and distress other than the intervention.
Second, a follow-up measurement is lacking. As fatigue is variable in
time, a follow-up is essential for evaluating the long term effects of
eMBCT. Third, the questionnaires were assessed by the same institute
that provided the intervention, therefore social desirability may have
inﬂuenced the results. The inﬂuence of social desirability may be less
if another party would assess the pre- and post-data. Unfortunately
38.5% patients did not ﬁll in the evaluation questionnaire, thus we
could not ﬁnd out their satisfaction with eMBCT. Monitoring adherent
and non-adherent patients is essential to get a clear view on the overall
patient's satisfaction with the intervention.
4.3. Comparison with prior work of others
As this is the ﬁrst study to investigate online individual web-
based MBCT for CRF, we will compare our results to other (online)
mindfulness-based interventions, or other online interventions.Our ﬁndings concerning the proportion of clinically relevant im-
proved patients (Jacobson and Truax, 1991) is slightly greater than in
group face-to-face MBCT for CRF (30%) (Van der Lee and Garssen,
2012), and individual face-to-face MBCT for depression in diabetes
patients (26%) (Tovote et al., 2014). It is slightly lower than the
40% that Boettcher et al. (2014) found in their online mindfulness-
based intervention for lowering severity of somatic and cognitive
anxiety symptoms in patients suffering from an anxiety disorder.
Yun et al. (2012) found that 56% of moderate to severely fatigued
cancer survivors were clinically meaningfully improved after a
web-based tailored education program. Though, they used a differ-
ent fatigue severity inventory and used a different statistical method
for clinically relevant improvement: they did not use the criterion
that the post-assessment fatigue severity score was within the nor-
mal range. Thus their deﬁnition of clinically relevant improvement
was less stringent than used in the current study and others (Van
der Lee and Garssen, 2012; Tovote et al., 2014).
Our non-adherence rate of 38.1% is within the found range of a
meta-analysis of face-to-face mindfulness-based interventions for sev-
eral disorders (anxiety depression, chronic pain, psoriasis) (3–40%,
M=25% (8.91) (Baer, 2003). Though, our non-adherence rate is slightly
higher than the results of a meta-analysis of nine web-based cognitive
behavior therapies for depression and anxiety (3–34%, M = 18%)
(Spek et al., 2007). Also, compared to studies investigating face-to-
face mindfulness-based interventions (Van der Lee and Garssen, 2012;
Table 3b
Demographic means for adherence.
Adherence t df
Demographics Adherent Non-adherent
Fatigue at baseline 46.12 (5.52) 47.19 (5.95) −1.47 255
Age 49.29 (9.89) 51.63 (11.81) −1.71 255
Time since cancer treatment 35.13 (41.56) 35.18 (35.58) − .01 150
Note. * = p b .05. Standard deviations appear in parentheses next to means. df=degrees
of freedom.
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should be noted that the ease to access online interventions (such as
the one evaluated in this study) may invite patients to apply, who
would never usually consider accessing a psychological face-to-face
intervention. Therefore online interventions may show higher non-
adherence rates (Christensen et al., 2009).
We need to learn from the feedback patients gave us on the use of
eMBCT.We have created a new version of eMBCT in a new ICT environ-
ment, as quite a large sample suggested improving the usability of the
webpage. We launched this new version in April 2013 and expect it to
be more user friendly. Regarding the intensity of the intervention, we
agree that eMBCT is an intensive course. The therapists encouraged
the patients to practice at least half an hour a day for six days a week,
try out the newmindfulness exercises and also do some of the exercises
of theweeks before, but in the same time respect their own boundaries.
Better informing the patients beforehand about the intensity of the pro-
gram may help decreasing disappointment, stress and non-adherence
rate. As the average duration of the intervention was 16weeks, we con-
sider spreading the protocol over a longer time period.
5. Conclusion
These ﬁndings indicate promising possibilities for eMBCT in treat-
ment of CRF. This pilot study involved a large sample size, the found sig-
niﬁcant decrease in fatigue severity had a high effect size, and a
substantial proportion was clinically relevant improved. The results of
this study are therefore informative, and suggest that individual
eMBCT may be effective in reducing fatigue in cancer survivors. A ran-
domized controlled study with a longer follow up is needed to demon-
strate the effectiveness of eMBCT. Moreover, it would be valuable to
investigate for which CRF patient eMBCT may be helpful in decreasing
fatigue severity, and how the decrease in fatigue severity is established.
Investigating thewritten correspondence between the therapist and the
patient, would be of great value in understanding the role of the thera-
pist and a possible variation in outcome between therapists. Currently,
we are investigating the newly designed eMBCT in a three-armed ran-
domized controlled trial funded by Alpe d'HuZes/KWF fund (Wolvers
et al., in press). This trial is registered in the Dutch Trial Registry, trial
number 3483: www.trialregister.nl, and results are expected in 2016.
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Overview of the e-MBCT protocol with the speciﬁc mindfulness
themes of each week Van der Lee and Garssen, 2012.
Week 1: Theme: the automatic pilot, do not strive.
Information about the stress-coping model and the ‘automatic pilot
mode’. Introduction to ‘eating with awareness’ and ‘body scan’. Home-
work: ‘eating with awareness’ and ‘body scan’. Addition: psycho-
education about coping with stress and fatigue and cancer-related
fatigue.
MP3 ﬁles: Body scan (32 min, woman)
Week 2: Theme: the body and the breath, do not judge.
Information about how to cope with pain and fatigue during the
body-scan exercise and how to handle thoughts during the ‘awareness
of breathing’ exercise. Homework: ‘breathing exercise’ and the ‘body
scan’ and noticing thoughts and feelings at nice or happymoments. Ad-
dition: tips for a better sleep quality.
MP3 ﬁles: Body scan with muscle tension, Jacoben (22 min. –man),
Attention to your breathing (14 min.- woman)
Week 3: Theme: accepting boundaries, acceptance.
Recognizing unpleasant experiences. Becoming aware of how one
deals with physical and emotional boundaries and cultivating accep-
tance. Three minute exercise focusing on breathing. Homework: ‘yoga
exercise’, ‘body scan’, ‘breathing exercises’. Addition: psycho-
education about how to build up energy and condition after cancer.
MP3ﬁles: Yoga (32min.–woman), Threeminute breathing exercise
(4 min. –woman)
Week 4: Theme: patience, attention.
Recognizing automatic negative cognitions, recognizing daily stress
inducing experiences and their emotional impact, promoting free
choice how to handle daily stress. Homework: ‘sitting with awareness’,’
walking with awareness’, alternated with previous learned exercises.
MP3 ﬁles: Sitting meditation (47 min. – man), Sitting meditation
(30 min. – woman)
Week 5: Theme: letting go, accept things as they are.
Learning how to cope with negative emotions through acceptation.
Keeping a diary of negative emotions. Homework: ‘accepting what is
in the present’, alternated with previous learned exercises.
MP3 ﬁles: Accepting what is in the present (23 min. – woman)
Week 6: Theme: dealing with thoughts and fear, trust.
Explanation how thoughts, behavior and emotions interact and how
one can choose to stop automatic reactions. Physiology of fear. Fear of
cancer recurrence. Dealing with loss. Homework: ‘walking with aware-
ness’ and ‘sitting with awareness’, alternated with previous learned
exercises.
MP3 ﬁles: Silence (20 min)
Week 7: Theme: silence and compassion, loving kindness to-
wards oneself.
Patients plan half a day with several awareness and compassion ex-
ercises at home in silence.
MP3 ﬁles: Mountain (16 min.—woman), Lake (20 min.—woman),
Lake (21 min. — man), Flower (15 min. — woman), Metta-meditation
(36 min.—woman)
Week 8: Theme: seeing from a new perspective: taking good care
of myself.
Participantsmake their ownprogramof exercises and planhow they
will continue the exercises without therapist feedback. Making a list of
the top ten of helpful cognitions. Accepting stress as a part of life. Home-
work: practice your own program of exercises.
Week 9: Theme: from stress to inner strength.
Repetition of previous themes. Recommended literature.
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We informedmedical doctors about the eMBCT via articles in relevant magazines, and informed patients directly by newsletters of patient asso-
ciations, and via advertisements on relevant websites in the Netherlands.Appendix C. Case volume
In this table the number of patients treated by each therapist is shown.Therapist Male/Female n
Therapist 1 F 3
Therapist 2 F 6
Therapist 3 F 20
Therapist 4 F 16
Therapist 5 F 6
Therapist 6 F 47
Therapist 7 F 61
Therapist 8 M 46
Therapist 9 F 35
Therapist 10 F 14
Therapist 11 M 2
Appendix D. Screenshots of eMBCT
209F.Z. Bruggeman Everts et al. / Internet Interventions 2 (2015) 200–213Figs. D.1 and D.2: Patients could log in on their personal password-protected webpage (D.1). where patients were introduced to the newmind-
fulness theme by their therapist (D.2).
210 F.Z. Bruggeman Everts et al. / Internet Interventions 2 (2015) 200–213Figs. D.3 and D.4: Patients downloaded mindfulness audio ﬁles (D.3), and downloaded written information following the speciﬁc mindfulness
theme of the week (D.4).
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212 F.Z. Bruggeman Everts et al. / Internet Interventions 2 (2015) 200–213Figs. D.5 and D.6: On their personal log on their webpage, patients wrote down their experiences after doing themindfulness exercises and read-
ing the weekly information. On an agreed day of the week, the therapists replied to this log, thereby guiding the patients through the nine-week
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